-
They note that Gilead froze prices through 2013 for drugs provided to ADAPs, or AIDS Drug Assistance Programs, run by the states.
FORBES: Gilead Warned By Democrats Over 'Quad' Pricing
-
Also known as ADAPs, these state programs provide meds to those with limited means, but are under financial pressure thanks to the recession.
FORBES: Backlash Over New Gilead AIDS Drug Begins
-
This action, alone, will not resolve the challenges faced by ADAPs.
WHITEHOUSE: Health Care Blog | The White House
-
Nonetheless, 21 ADAPs, including seven with current waiting lists, have instituted additional cost-cutting steps over the past three years and two ADAPs are considering new or additional measures by March 2013 ( read here).
FORBES: Backlash Over New Gilead AIDS Drug Begins
-
We need States to continue to prioritize their funding for ADAPs even in these difficult times, and we need our pharmaceutical company partners, businesses, foundations, and community-based organizations to do their part as well.
WHITEHOUSE: Health Care Blog | The White House
-
Nonetheless, 21 ADAPs, including seven with current waiting lists, have instituted additional cost-cutting steps over the past three years and two ADAPs are considering new or additional measures by March 2013 ( you can read more here).
FORBES: Gilead Warned By Democrats Over 'Quad' Pricing
-
They noted that, while Gilead froze prices through 2013 for drugs provided to ADAPs, the drugmaker boosted prices for its meds in the commercial market, which could cause Ryan White Part B-funded co-pays and deductibles to rise and leave less funding available for ADAP ( back story).
FORBES: Backlash Over New Gilead AIDS Drug Begins